Allianz Asset Management Gmb H Medpace Holdings, Inc. Transaction History

Allianz Asset Management Gmb H

  • $70.3 Billion
  • Q1 2025

A detailed history of Allianz Asset Management Gmb H transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 1,845 shares of MEDP stock, worth $542,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,845
Previous 5,484 66.36%
Holding current value
$542,079
Previous $1.82 Million 69.14%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025
SELL
$304.69 - $360.97 $1.11 Million - $1.31 Million
-3,639 Reduced 66.36%
1,845 $562,000
Q4 2024

Feb 03, 2025
SELL
$308.93 - $363.58 $756,260 - $890,043
-2,448 Reduced 30.86%
5,484 $1.82 Million
Q3 2024

Nov 12, 2024
SELL
$320.58 - $457.29 $2.96 Million - $4.23 Million
-9,248 Reduced 53.83%
7,932 $2.65 Million
Q2 2024

Aug 13, 2024
BUY
$372.0 - $424.34 $39,060 - $44,555
105 Added 0.61%
17,180 $7.08 Million
Q1 2024

May 13, 2024
BUY
$284.87 - $413.31 $335,576 - $486,879
1,178 Added 7.41%
17,075 $6.9 Million
Q4 2023

Feb 12, 2024
BUY
$227.52 - $312.68 $327,628 - $450,259
1,440 Added 9.96%
15,897 $4.87 Million
Q3 2023

Nov 13, 2023
SELL
$233.98 - $281.67 $532,538 - $641,080
-2,276 Reduced 13.6%
14,457 $3.5 Million
Q2 2023

Aug 11, 2023
SELL
$187.26 - $240.17 $2.48 Million - $3.19 Million
-13,270 Reduced 44.23%
16,733 $4.02 Million
Q1 2023

May 11, 2023
BUY
$174.31 - $239.52 $5.23 Million - $7.19 Million
30,003 New
30,003 $5.64 Million
Q2 2022

Aug 12, 2022
SELL
$130.2 - $168.03 $1.34 Million - $1.72 Million
-10,264 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$138.87 - $214.31 $2.22 Million - $3.43 Million
-16,004 Reduced 60.93%
10,264 $1.68 Million
Q4 2021

Feb 11, 2022
SELL
$182.74 - $227.9 $3.03 Million - $3.78 Million
-16,570 Reduced 38.68%
26,268 $5.72 Million
Q3 2021

Nov 10, 2021
BUY
$170.18 - $198.21 $4.55 Million - $5.3 Million
26,762 Added 166.47%
42,838 $8.11 Million
Q2 2021

Aug 16, 2021
SELL
$158.62 - $194.3 $173,530 - $212,564
-1,094 Reduced 6.37%
16,076 $2.84 Million
Q1 2021

May 13, 2021
SELL
$132.02 - $168.26 $3.5 Million - $4.46 Million
-26,479 Reduced 60.66%
17,170 $2.82 Million
Q4 2020

Feb 16, 2021
SELL
$109.38 - $149.19 $281,544 - $384,015
-2,574 Reduced 5.57%
43,649 $6.08 Million
Q3 2020

Nov 13, 2020
SELL
$92.95 - $130.61 $1.03 Million - $1.44 Million
-11,043 Reduced 19.28%
46,223 $5.17 Million
Q2 2020

Aug 14, 2020
SELL
$68.08 - $95.68 $757,526 - $1.06 Million
-11,127 Reduced 16.27%
57,266 $5.33 Million
Q1 2020

May 14, 2020
SELL
$61.71 - $101.95 $3.29 Million - $5.44 Million
-53,365 Reduced 43.83%
68,393 $5.02 Million
Q4 2019

Feb 13, 2020
BUY
$70.08 - $84.64 $3.83 Million - $4.63 Million
54,694 Added 81.55%
121,758 $10.2 Million
Q3 2019

Nov 13, 2019
SELL
$62.38 - $85.89 $3.16 Million - $4.35 Million
-50,591 Reduced 43.0%
67,064 $5.64 Million
Q2 2019

Aug 08, 2019
BUY
$53.64 - $65.42 $737,174 - $899,067
13,743 Added 13.23%
117,655 $7.7 Million
Q1 2019

May 13, 2019
BUY
$49.38 - $70.58 $1.51 Million - $2.15 Million
30,495 Added 41.54%
103,912 $6.13 Million
Q4 2018

Feb 14, 2019
SELL
$46.97 - $63.98 $320,711 - $436,855
-6,828 Reduced 8.51%
73,417 $3.89 Million
Q3 2018

Nov 13, 2018
SELL
$43.25 - $63.74 $128,236 - $188,989
-2,965 Reduced 3.56%
80,245 $4.81 Million
Q2 2018

Aug 13, 2018
SELL
$34.03 - $45.46 $35,901 - $47,960
-1,055 Reduced 1.25%
83,210 $3.58 Million
Q1 2018

May 14, 2018
BUY
$32.03 - $39.05 $2.02 Million - $2.47 Million
63,165 Added 299.36%
84,265 $2.94 Million
Q4 2017

Feb 13, 2018
BUY
$32.46 - $38.31 $684,906 - $808,341
21,100
21,100 $765,000

Others Institutions Holding MEDP

# of Institutions
624
Shares Held
26M
Call Options Held
46.4K
Put Options Held
80.8K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.14B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email